AbbVie Inc Stock Investing
| ABBV Stock | USD 171.73 3.97 2.37% |
Investing in stocks, such as AbbVie, is an excellent way to grow wealth. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. Numerous studies have shown that most market-timers underperform compared to investors who buy and hold a diversified portfolio over the long term. Additionally, the costs associated with frequent trading can erode profits.
The event calendar will help you understand the most critical current and past headlines together with many other corporate specific events such as SEC filings, dividends, and regulatory reporting available to the public. Some investors and traders attempt market timing as part of their overall investment strategy, aiming to maximize returns and minimize losses. It's crucial for those attempting to time the market to understand the risks involved, to have a well-thought-out investment plan, and to be prepared for the potential consequences of incorrect predictions.
EPS Estimate Next Quarter 2.95 | 200 Day MA 178.8994 | EPS Estimate Next Year 12.1456 | Shares Short Prior Month 14.9 M | 50 Day MA 190.7812 |
AbbVie |
It is important to use AbbVie's's Calendar properly to avoid purchasing assets when they are expected to decrease in value and to sell them when they are expected to increase. This contrasts with long-term investment strategies like buy-and-hold, where an investor buys an asset with the expectation of long-term growth, regardless of short-term price volatility. The right investment tools help us make smart, informed decisions about our financial future. Using inadequate tools for your investment process almost always guarantees poor results. Traditionally, people think of investment tools as brokerage accounts that enable investors to buy or sell AbbVie Inc or other financial instruments. Most brokerage firms offer research tools, but many of these tools are either unsophisticated or difficult for retail investors interested in AbbVie Inc to apply. See below for AbbVie's's investment analysis tools that can help you make an informed investment decision.
Being informed about the market onlook and anticipating its possible future direction always helps investors rip off the higher ROI. Unlike 30 years ago, retail investors have a wealth of information at their fingertips about the stock market, and some may even say they have too much. All the investing-related noise out there is simply impossible for the average lay investor to process. This is especially true if you want to build and manage a diversified portfolio comprised mainly of individual stocks. To originate a well-balanced portfolio requires access to reliable, expert-level sources of actionable information about equities such as AbbVie Inc.
Far too much social signal, news, headlines, and media speculation about AbbVie that are available to investors today. That information is available publicly through AbbVie media outlets and privately through word of mouth or via AbbVie internal channels. However, regardless of the origin, that massive amount of AbbVie data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AbbVie news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AbbVie relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AbbVie's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AbbVie alpha.
AbbVie Stock Historical Chart
Most investors accept the general idea that the market moves back and forth in trends. These trends are simply referred to as bull and bear market cycles. Each bull market begins after a day that signals the beginning of a new uptrend, whereas every bear market starts after the long-term downward trend is projected forward. Using AbbVie stock market historical data and studying specific examples from the stock market past, makes it easier to put current market moves in context, while making an informed buy or sell decision.
AbbVie Investment Analysis Tools
This is a quick snapshot of AbbVie Inc research areas. You can expand your research by examining different market driven as well as company-specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and many other powerfull tools.
Quote & Profile
Earnings Estimate
Updated
Fundamental Analysis
Event Calendar
Updated
Technical Analysis
Momentum Indicators
Updated
Alpha Analysis
Chance of Bankruptcy
Pattern Recognition
Current Valuation
News and Headlines
Bollinger Bands
Historical Volatility
Updated
Correlation With Market
Backtesting
Compare to peers
Management
Performance
Risk-adjusted Advice
Power Widgets
Price Prediction
Updated
Analyst Recommendations
Piotroski F Score
Fundamental History
Revenue
Updated
Net Income Analysis
Financial Leverage
Balance Of Power
Price History
Updated
Pair Correlation
AbbVie vs. Small Cap
AbbVie Upcoming and Recent Events
In most cases, entities such as AbbVie have five main reporting periods - one for each fiscal quarter and one for the fiscal year. The fiscal year for most companies runs from January 1st to December 31st. The standard calendar quarters that make up the year are usually January, April, July, and October. These dates are essential for AbbVie Inc stakeholders because AbbVie provides information to its current and potential investors on these particular dates. AbbVie prospectus issued under the SEC's guidelines is a legal declaration of facts and statements to ensure that AbbVie investors are not misled.
| 2nd of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 2nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
AbbVie Corporate Reports
10Q | 4th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 30th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 2nd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of August 2024 Other Reports | ViewVerify |
AbbVie Distributions to stockholders
A dividend is the distribution of a portion of AbbVie earnings, decided and managed by the AbbVies board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. AbbVie dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment.| 15th of November 2024 | ||
| 15th of August 2024 | ||
| 15th of May 2024 | ||
| 15th of February 2024 | ||
| 15th of November 2023 | ||
| 15th of August 2023 | ||
| 15th of May 2023 | ||
| 15th of February 2023 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.